Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Cytek Biosciences  (Stock symbol: CTKB )

46107 Landing Pkwy
Fremont, CA 94538
USA
(510) 657-0102
Website Company Summary Management Team
Management

CEO: Wenbin Jiang (2015)
President/COO/Operations: Melik Ulusu (2/29/2020)
General Management: Ken Riley (2/28/2016)
Finance: Patrik Sebastian Jeanmonod (10/31/2018)
Technology: Ming Yan (5/31/2015)
Sales/Marketing: Steve Ziganti ; Gil Reinin
General Counsel/Legal: Valerie Barnett
Board

Outside board: (May no longer be on the board) Feng Deng (Northern Light Venture Capital General Partner) Kevin Yan (Innovex Medical President) Xin Huang (Cowin Venture Managing Partner) Allen Poirson (twoXAR SVP Biopharmaceutical Business Development) Andrew Levin (RA Capital Managing Director) Jack Ball (Teitelbaum Foundation CEO)
Company

Business description: Cytek Biosciences Inc. is a leading flow cytometry solution provider that develops compact, affordable instruments with high multiplexing capability and a wide range of services to support scientists and clinicians. Cytek also offers proprietary cFluorTM reagents, which ensure optimal performance for users of its instruments in a multicolor environment. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe.
Capital

Rounds: 3
Recent Fundings: Nov 2020   Sep 2018
Capital raised: 132.2M
Last Round: 120.0M
Ownership: Private   Ipo Filing
Stock Symbol: CTKB
VCs include: OrbiMed ;  RA Capital ;  Eight Roads Ventures ;  Northern Lights Ventures ;  3E Bioventures ;  Hillhouse Capital ;  LYFE Capital

Last Tweets


 

Last Mentions


Overview
Record updated: Jul 2021
Sector: Medical
Year Founded: 1992
Headcount: 201-300 as of Jul 2021
Rounds: 3
Recent Fundings: Nov 2020   Sep 2018
Capital Raised: 132.2M
Last Round: 120.0M
Ownership: Private   Ipo Filing
Stock Symbol: CTKB